Cite
HARVARD Citation
O'Donovan, M. et al. (2021). Recombinant factor IX‐Fc fusion protein in severe hemophilia B: Patient‐reported outcomes and health‐related quality of life. Research and practice in thrombosis and haemostasis. 5 (7), p. n/a. [Online].